Acadian Asset Management
GMAB icon

Acadian Asset Management’s Genmab GMAB Stock Holding History

Acadian Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,044
Closed -$32K – 2099
2025
Q4 		$32K Hold
1,044
– – ﹤0.01% 1848
2025
Q3 		$32K Buy
+1,044
New +$25.4K ﹤0.01% 1709
2025
Q2 		– Sell
-6,719
Closed -$131K – 1723
2025
Q1 		$131K Sell
6,719
-9,729
-59% -$204K ﹤0.01% 1312
2024
Q4 		$343K Sell
16,448
-31,568
-66% -$694K ﹤0.01% 1161
2024
Q3 		$1.17M Buy
48,016
+10,006
+26% +$268K ﹤0.01% 881
2024
Q2 		$954K Buy
38,010
+29,762
+361% +$844K ﹤0.01% 1010
2024
Q1 		$245K Sell
8,248
-6,421
-44% -$189K ﹤0.01% 1156
2023
Q4 		$466K Sell
14,669
-36,625
-71% -$1.15M ﹤0.01% 1037
2023
Q3 		$1.81M Sell
51,294
-22,700
-31% -$865K 0.01% 718
2023
Q2 		$2.81M Sell
73,994
-9,891
-12% -$394K 0.01% 611
2023
Q1 		$3.16M Sell
83,885
-95,467
-53% -$3.67M 0.01% 583
2022
Q4 		$7.6M Buy
179,352
+146,365
+444% +$6.03M 0.04% 335
2022
Q3 		$1.06M Buy
32,987
+1,943
+6% +$68.2K 0.01% 792
2022
Q2 		$1.01M Hold
31,044
– – 0.01% 815
2022
Q1 		$1.12M Sell
31,044
-37,368
-55% -$1.28M ﹤0.01% 805
2021
Q4 		$2.7M Hold
68,412
– – 0.01% 587
2021
Q3 		$2.99M Buy
68,412
+1,089
+2% +$48.9K 0.01% 576
2021
Q2 		$2.75M Buy
+67,323
New +$2.6M 0.01% 624
2021
Q1 		– Sell
-574
Closed -$23K – 2163
2020
Q4 		$23K Sell
574
-7,963
-93% -$298K ﹤0.01% 2126
2020
Q3 		$313K Buy
8,537
+7,171
+525% +$259K ﹤0.01% 1287
2020
Q2 		$46K Buy
+1,366
New +$37.2K ﹤0.01% 1947

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Acadian Asset Management's GMAB Position: Q1 2026 in Review

Acadian Asset Management sold out of Genmab (GMAB) in Q1 2026, closing a stake of 1,044 shares — an estimated $32K sold.

Acadian Asset Management first reported a position in GMAB in Q2 2020 and held it in 21 quarters. The position peaked at $7.6M in Q4 2022. 273 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Acadian Asset Management reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • Acadian Asset Management sold 1,044 Genmab shares in Q1 2026, an estimated $32K.
  • Acadian Asset Management first reported a position in Genmab in Q2 2020 and held it in 21 quarters.
  • Acadian Asset Management's Genmab position peaked at $7.6M in Q4 2022.
  • 273 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.